ProImmune and Pirbright collaborate to advance animal health
Posted: 1 October, 2024
A strategic partnership between The Pirbright Institute and ProImmune aims to develop target-binding reagents that significantly accelerate research in animal health.
Ankyrons™ are small, recombinant, target binding ankyrin repeat proteins developed by ProImmune. They are directly selected in vitro from a trillion-clone library in ribosome display and, like antibodies, can bind with high affinity to almost any target.
